Breakthrough Precision
Medicines for ALS
Medicines for ALS
Bringing Hope to Patients
Conquering ALS
QurAlis
Platform
QurAlis Platform
Antisense oligonucleotides (ASOs) are short, engineered single-stranded DNA/RNA molecules that can selectively bind RNA to prevent or reduce its expression in the cell.
LEARN MORE
A Message
of Hope
Careers at QurAlis
Careers at QurAlis
As a member of the QurAlis team, you become part of our mission to conquer ALS and FTD
LEARN MORE
QurAlis
Platform
QurAlis Platform
Antisense oligonucleotides (ASOs) are short, engineered single-stranded DNA/RNA molecules that can selectively bind RNA to prevent or reduce its expression in the cell.
LEARN MORE
A Message
of Hope
A Message
of Hope
We are leading the charge to conquer ALS.
LEARN MORE
Careers at
QurAlis
Careers at
QurAlis
As a member of the QurAlis team, you become part of our mission to conquer ALS and FTD
LEARN MORE
Latest News
QurAlis’ Selective Kv7 Opener, a Drug Candidate for ALS, Demonstrates up to 20-Fold Increase in Potency and Dramatic Reduction in Side Effects Compared to Retigabine in Preclinical Models